Correspondence on "development and validation of a nomogram to predict the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma"

被引：0
|
作者：
Ragavendran, Chinnasamy [1 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Cariol, Chennai 600077, India
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s12094-024-03808-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1853 / 1854
页数：2
相关论文
共 50 条
  • [1] Development and validation of a nomogram to predicting the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma
    Chen, Yao
    Chen, Dubo
    Wang, Ruizhi
    Xie, Shuhua
    Wang, Xueping
    Huang, Hao
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (10): : 2601 - 2607
  • [2] Targeting the PD-1/PD-L1 interaction in nasopharyngeal carcinoma
    Johnson, David
    Ma, Brigette B. Y.
    ORAL ONCOLOGY, 2021, 113
  • [3] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [4] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Ming Yi
    Dechao Jiao
    Hanxiao Xu
    Qian Liu
    Weiheng Zhao
    Xinwei Han
    Kongming Wu
    Molecular Cancer, 17
  • [5] Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
    Yi, Ming
    Jiao, Dechao
    Xu, Hanxiao
    Liu, Qian
    Zhao, Weiheng
    Han, Xinwei
    Wu, Kongming
    MOLECULAR CANCER, 2018, 17
  • [6] Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
    Lee, Jiyun
    La Choi, Yoon
    Jung, Hyun Ae
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    EUROPEAN JOURNAL OF CANCER, 2020, 132 : 150 - 158
  • [7] The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Wang, Bi-Cheng
    Cao, Ru-Bo
    Fu, Chen
    Chen, Wang-Bing
    Li, Pin-Dong
    Lin, Guo-He
    Qian, Xiao-Jun
    Li, Yun-Tian
    Liu, Quentin
    ORAL ONCOLOGY, 2020, 104
  • [8] Trends in clinical development for PD-1/PD-L1 inhibitors
    Yu, Jia Xin
    Hodge, Jeffrey P.
    Oliva, Cristina
    Neftelinov, Svetoslav T.
    Hubbard-Lucey, Vanessa M.
    Tang, Jun
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 163 - 164
  • [9] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [10] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
12345